首页> 外国专利> Method for preparing acid ethyl ester (22.45) - 4 - (3,5-bis (trifluoromethyl - - Methoxycarbonyl benzyl) amino ethyl - 2 - 6 - trifluoromethyl - 3,4-dihydro - 2H - quinoline - 1 - carboxylic acid anhydrous

Method for preparing acid ethyl ester (22.45) - 4 - (3,5-bis (trifluoromethyl - - Methoxycarbonyl benzyl) amino ethyl - 2 - 6 - trifluoromethyl - 3,4-dihydro - 2H - quinoline - 1 - carboxylic acid anhydrous

机译:制备酸乙酯(22.45)-[4-(3,5-双(三氟甲基-甲氧羰基苄基)氨基]氨基]乙基-2--6-三氟甲基-3,4-二氢-2H-喹啉-1-羧酸的方法无水的

摘要

1. Preparation of ester (2R, 4S) - 4 - [(3, 5-bis-trifluorometil-bencil) - methylamine] - 2-ethyl-6-trifluoromethyl-3, 4-dihydro-2h-quinolin-1-carboxylico anhydro de form (1),It includes: combining ethyl ester (2R, 4S) - 4 - [(3, 5-bis-trifluoro-benzene) - methoxy-amine] - 2-ethyl-6-trifluoro-trifluoro-3, 4-dihydro-2h-quinine-1-carboxy with a solvent at a temperature sufficient to dissolve the ethyl ester (2R, 4S) - 4 - [(3), 5-bis-trifluoro-metal-bencil) - metaloxicarbonil-amine] - 2-ethyl-6-trifluoro methyl-3, 4-dihydro-2h-quinlin-1-carboxyl for a solution, which fall includes heptanos or a composite of water and a pol;2. [(3,5-bis-trifluorometarbone-amine] - 2-ethyl-6-trifluorometarbone-3,4-dihydro-2h-quinlin-1-carboxyl-solid, including the formation to cool or evaporate the solution so that the solvent in the solution is sufficient to form the ethyl acetate (2R, 4S) - 4 - [(3), 5-bis-trifluoro-metallic-bencil) - methoxicarbone amine] - 2-ethyl-6-trifluoro-metallic-3, 4-dihydro-2h-quinlin-1-carboxyl solid;2. The ethyl ester was separated from acid (2R, 4S) - 4 - [(3, 5-bis-trifluoromethyl-bencil) - metrobonil-amine] - 2-ethyl 6-trifluoromethyl-3, 4-dihydro-2h-quinlin-1-carboxyl in solid solvent to obtain Ethyl Acid (2R, 4S) - 4 - [(3, 5-bis-trifluoromethyl-bencil) - amine-3] - trifluoroethane] - 3; 4-dihydro-2H-quinolin-1-anhydro carboxyl. These compounds are inhibitors of cholesterol ester transfer proteins.
机译:1.酯(2R,4S)的制备-4-[(3,5-双三氟甲基苯甲酸酯)-甲胺]-2-乙基-6-三氟甲基-3,4-二氢-2h-喹啉-1-羧酸脱水形式(1),包括:混合乙酯(2R,4S)-4-[[(3,5-双三氟苯)-甲氧基胺]-2-乙基-6-三氟三氟-3 ,在足以溶解乙酯(2R,4S)-4-[(3),5-双三氟金属-苯甲酸酯)-金属氧羰基-胺]-2-乙基-6-三氟甲基-3,4-二氢-2h-喹啉-1-羧基,其溶液包括庚烷或水和pol的复合物; 2。 [(3,5-双三氟甲基戊胺]-2-乙基-6-三氟甲基戊烷-3,4-二氢-2h-喹啉-1-羧基固体,包括冷却或蒸发溶液形成的溶液,以便使溶剂在溶液中足以形成乙酸乙酯(2R,4S)-4-[(3),5-双-三氟-金属-苯甲酸酯)-甲氧羰基胺]-2-乙基-6-三氟-金属-3, 4-二氢-2h-喹啉-1-羧基固体; 2。将乙酯与酸(2R,4S)-4-[(3,5-双三氟甲基苯甲酸酯)-甲萘醌]-2-乙基6-三氟甲基-3,4-二氢-2h-喹啉-分离在固体溶剂中用1-羧基得到乙酯酸(2R,4S)-4-[(3,5-双三氟甲基苯)-胺-3]-三氟乙烷]-3; 4-二氢-2H-喹啉-1-无水羧基。这些化合物是胆固醇酯转移蛋白的抑制剂。

著录项

  • 公开/公告号AR037325A1

    专利类型

  • 公开/公告日2004-11-03

    原文格式PDF

  • 申请/专利权人 PFIZER PRODUCTS INC.;

    申请/专利号AR2002P103632

  • 发明设计人

    申请日2002-09-26

  • 分类号C07D215/42;A61K31/47;A61P9/10;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号